Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Genet Dev. 2007 Jun;17(3):182-92. Epub 2007 Apr 30.

    Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation.

    Source

    Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

    Abstract

    The clinical implementation of array comparative genomic hybridization has revolutionized the diagnosis of patients with syndromic or nonsyndromic mental retardation. Multiple studies of hundreds of patients with idiopathic mental retardation, and normal karyotype and/or subtelomeric testing using genome-wide microarray platforms with approximately 2000 to >30,000 (tiling-path) interrogating BAC/PAC probes have detected chromosome abnormalities in up to 17% of cases. Surprisingly, some of the pathogenic changes are mosaic and not detectable in conventional karyotyping. Commercially available genome-wide microarrays with >300,000 synthesized oligonucleotide probes enable higher resolution and sensitivity and will probably replace the BAC/PAC arrays in clinical laboratories.

    PMID:
    17467974
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk